• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.20%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.01 Up 0.01(0.20%) 3:24PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.00
    Open:4.99
    Bid:5.00 x 6300
    Ask:5.01 x 2600
    1y Target Est:11.57
    Beta:2.15
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:4.92 - 5.09
    52wk Range:3.11 - 9.37
    Volume:1,455,430
    Avg Vol (3m):6,166,900
    Market Cap:619.88M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 0.20%619.88M
    ABTDown 0.49%73.09B
    GSKDown 0.54%109.44B
    RHHBYDown 0.78%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Jun-15) :-0.16
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback